Piper Sandler Reiterates Overweight on Omnicell, Lowers Price Target to $45

Benzinga · 08/03 16:04
Piper Sandler analyst Jessica Tassan reiterates Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $55 to $45.